Published in Clin Exp Immunol on July 05, 2007
p38MAPK, ERK and PI3K signaling pathways are involved in C5a-primed neutrophils for ANCA-mediated activation. PLoS One (2012) 1.01
Translational mini-review series on immunology of vascular disease: mechanisms of vascular inflammation and remodelling in systemic vasculitis. Clin Exp Immunol (2009) 0.95
An approach to the diagnosis and management of systemic vasculitis. Clin Exp Immunol (2010) 0.95
PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC). PLoS One (2014) 0.88
Detection of Anti-Pentraxin-3 Autoantibodies in ANCA-Associated Vasculitis. PLoS One (2016) 0.85
Novel clinical and diagnostic aspects of antineutrophil cytoplasmic antibodies. J Immunol Res (2014) 0.82
The interaction between C5a and sphingosine-1-phosphate in neutrophils for antineutrophil cytoplasmic antibody mediated activation. Arthritis Res Ther (2014) 0.80
High mobility group box 1 contributes to anti-neutrophil cytoplasmic antibody-induced neutrophils activation through receptor for advanced glycation end products (RAGE) and Toll-like receptor 4. Arthritis Res Ther (2015) 0.80
ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients. Nat Rev Rheumatol (2016) 0.80
Automatic reading of ANCA-slides: evaluation of the AKLIDES system. Clin Dev Immunol (2012) 0.78
A Case of Concurrent MPO-/PR3-Negative ANCA-Associated Glomerulonephritis and Membranous Glomerulopathy. Case Rep Nephrol (2015) 0.75
A pro-inflammatory role of C5L2 in C5a-primed neutrophils for ANCA-induced activation. PLoS One (2013) 0.75
Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum (1994) 14.16
Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet (1985) 10.67
Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med (1988) 8.01
Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest (1989) 3.34
Antineutrophil cytoplasmic antibodies. Arthritis Rheum (1998) 2.53
Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis. QJM (1996) 1.78
Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int (2000) 1.64
Genomic organization and chromosomal localization of the human cathepsin G gene. J Biol Chem (1989) 1.52
Anti-cathepsin G antibodies in the sera of patients with ulcerative colitis. J Gastroenterol (2000) 1.49
Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum (1992) 1.44
Circulating anti-elastase in systemic lupus erythematosus. Lancet (1989) 1.33
Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions. Arthritis Care Res (2000) 1.20
Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis. Nephrol Dial Transplant (1991) 1.18
Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arthritis Rheum (2004) 1.15
Antineutrophil cytoplasmic antibodies (ANCA). Autoimmunity (2005) 1.15
Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates. Clin Rheumatol (2004) 0.97
Anti-neutrophil cytoplasmic antibodies (ANCA): their detection and significance: report from workshops. Pathology (1994) 0.94
Anti-neutrophil cytoplasmic antibody (ANCA) in malaria is directed against cathepsin G. Clin Exp Immunol (1997) 0.93
The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil. Int Immunopharmacol (2006) 0.86
Endothelial tissue factor stimulation by proteinase 3 and elastase. Clin Exp Immunol (2001) 0.84
Anti-neutrophil cytoplasmic antibodies directed against the bactericidal/permeability-increasing protein (BPI) in pediatric cystic fibrosis patients do not recognize N-terminal regions important for the anti-microbial and lipopolysaccharide-binding activity of BPI. Pediatr Allergy Immunol (2000) 0.84
Anti-myeloperoxidase antibodies in Churg-Strauss syndrome. J Neurol (1993) 0.83
Neutrophil involvement in inflammatory tissue damage. Neth J Med (1990) 0.83
Recognition of bactericidal/permeability-increasing protein by perinuclear anti-neutrophil cytoplasmic antibody-positive sera from ulcerative colitis patients: prevalence and clinical significance. Scand J Gastroenterol (1998) 0.83
[Clinicopathological characteristics of propylthiouracil-induced antineutrophil cytoplasmic antibodies-positive vasculitis and their target antigens: a report of 4 cases and literature review]. Zhonghua Nei Ke Za Zhi (2002) 0.82
Antineutrophil cytoplasmic antibody in patients with primary Sjögren's syndrome. Clin Rheumatol (1999) 0.80
Autoantibodies and target antigens in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides. Rheumatol Int (1996) 0.77
Antineutrophil cytoplasmic antibodies in Bulgarian patients with rheumatoid arthritis: characterization and clinical associations. Rheumatol Int (2004) 0.77
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum (2013) 11.18
A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med (1995) 6.14
Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol (1997) 5.94
Autoimmune murine thyroiditis relation to histocompatibility (H-2) type. Science (1971) 3.31
Clinicopathologic description of myocarditis. J Am Coll Cardiol (1991) 3.20
Dynamic changes of the inflammation-based index predict mortality following chemoembolisation for hepatocellular carcinoma: a prospective study. Aliment Pharmacol Ther (2014) 2.66
Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol (1987) 2.65
CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography. AJNR Am J Neuroradiol (1999) 2.43
Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to Coxsackievirus B3-induced myocarditis. J Immunol (1987) 2.28
Hypothesis: the aging paradox and autoimmune disease. Autoimmunity (1991) 2.09
Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol (2005) 2.07
Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice. J Immunol (1986) 1.86
In vitro lymphocyte transformation in atopic patients: induced by antigens. J Allergy (1967) 1.78
Murine thyroiditis: importance of adjuvant and mouse strain for the induction of thyroid lesions. J Immunol (1971) 1.76
Induction of autoimmunity in good and poor responder mice with mouse thyroglobulin and lipopolysaccharide. J Exp Med (1977) 1.73
Cellular basis of the genetic control of immune responsiveness to murine thyroglobulin in mice. Cell Immunol (1975) 1.72
Gastric 'pseudolipomatosis'. Histopathology (1998) 1.71
Transfer of experimental autoimmune thyroiditis of the mouse by serum. J Immunol (1971) 1.71
From infection to autoimmunity. J Autoimmun (2001) 1.59
Studies on experimental thyroiditis. Ann N Y Acad Sci (1965) 1.57
Iodine-induced autoimmune thyroiditis in NOD-H-2h4 mice. Clin Immunol Immunopathol (1996) 1.57
Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis. J Exp Med (1985) 1.55
Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am J Pathol (2001) 1.52
Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer (1995) 1.51
The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease. Ann Oncol (2009) 1.46
Interleukin 1 or tumor necrosis factor can promote Coxsackie B3-induced myocarditis in resistant B10.A mice. J Exp Med (1992) 1.45
Dyspnoea after antiplatelet agents: the AZD6140 controversy. Int J Clin Pract (2007) 1.45
Reliability of normal findings on MR imaging for excluding the diagnosis of vasculitis of the central nervous system. AJR Am J Roentgenol (2001) 1.44
Management of complex colonic polyps in the English Bowel Cancer Screening Programme. Br J Surg (2013) 1.42
Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica. Arthritis Care Res (Hoboken) (2012) 1.41
Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway. Circulation (2001) 1.40
Heart-specific autoantibodies induced by Coxsackievirus B3: identification of heart autoantigens. Clin Immunol Immunopathol (1987) 1.40
T-cell regulation in autoimmune thyroiditis. Immunol Rev (1981) 1.40
Coxsackievirus B3 murine myocarditis: a pathologic spectrum of myocarditis in genetically defined inbred strains. J Am Coll Cardiol (1987) 1.39
Biologic activity of extracts of delayed hypersensitivity skin reaction sites. Cell Immunol (1973) 1.39
Mercury exposure, malaria, and serum antinuclear/antinucleolar antibodies in Amazon populations in Brazil: a cross-sectional study. Environ Health (2004) 1.38
The silicone breast implant controversy: the other courtroom. Arthritis Rheum (1996) 1.38
Nitric oxide inhibits viral replication in murine myocarditis. J Clin Invest (1996) 1.36
Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment. Br J Cancer (2008) 1.34
Autoimmune murine thyroiditis. IV. Localization of genetic control of the immune response. J Immunol (1974) 1.34
Regulation of autoimmune response to mouse thyroglobulin: influence of H-2D-end genes. J Immunol (1979) 1.34
Syngeneic thyroglobulin is immunogenic in good responder mice. Eur J Immunol (1981) 1.31
Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis. J Immunol (1993) 1.30
Experimental autoimmune thyroiditis. In vitro cytotoxic effects of T lymphocytes on thyroid monolayers. J Exp Med (1983) 1.30
Contribution of the innate immune system to autoimmune myocarditis: a role for complement. Nat Immunol (2001) 1.30
The presence of thyroid autoantibodies in children and adolescents with autoimmune thyroid disease and in their siblings and parents. Clin Immunol Immunopathol (1982) 1.29
In vitro susceptibility of Neisseria gonorrhoeae to spectinomycin examined by a broth dilution method. Antimicrob Agents Chemother (1973) 1.25
Cytotoxicity of human thyroid autoantibodies. Ann N Y Acad Sci (1965) 1.24
Experimental thyroiditis in the rhesus monkey. I. Cytotoxic, mixed-agglutinating and complement-fixing antibodies. Clin Exp Immunol (1966) 1.23
Neonatal thymectomy increases spontaneous autoimmune thyroiditis. J Immunol (1973) 1.23
British HIV Association guidelines for HIV-associated malignancies 2008. HIV Med (2008) 1.23
Tolerance to thyroglobulin by activating suppressor mechanisms. Ann N Y Acad Sci (1982) 1.22
Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone. HIV Med (2005) 1.22
Autoimmune myocarditis: a paradigm of post-infection autoimmune disease. Immunol Today (1988) 1.21
Neonatal thymectomy increases the incidence of spontaneous and methylcholanthrene-enhanced thyroiditis in rats. Science (1974) 1.21
Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions. Arthritis Care Res (2000) 1.20
Splitting of human thyroglobulin. I. Reduction and alkylation. Clin Exp Immunol (1969) 1.19
Experimental thyroiditis in the rhesus monkey. 3. Course of the disease. Clin Exp Immunol (1966) 1.18
The effects of trastuzumab on the CD4+CD25+FoxP3+ and CD4+IL17A+ T-cell axis in patients with breast cancer. Br J Cancer (2009) 1.16
Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J Am Coll Cardiol (1990) 1.14
Postinfectious autoimmunity: two distinct phases of coxsackievirus B3-induced myocarditis. Ann N Y Acad Sci (1986) 1.14
Hypothyroidism in transgenic mice expressing IFN-gamma in the thyroid. Proc Natl Acad Sci U S A (2000) 1.13
An enzyme-linked immunosorbent assay (ELISA) for antibodies to thyroglobulin. Proc Soc Exp Biol Med (1980) 1.13
Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis. Ann Rheum Dis (2008) 1.12
Mouse thyroid primary culture. Biochem Biophys Res Commun (1999) 1.12
Regulation of experimental autoimmune thyroiditis: mapping of susceptibility to the I-A subregion of the mouse H-2. Immunogenetics (1982) 1.12
Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: a nonhistologic marker of myocarditis. J Am Coll Cardiol (1990) 1.11
Inflammatory heart disease: a role for cytokines. Lupus (2005) 1.11
Coxsackievirus induced myocarditis in mice: cardiac myosin autoantibodies do not cross-react with the virus. Clin Exp Immunol (1987) 1.11
Viral damage or 'molecular mimicry'-placing the blame in myocarditis. Nat Med (2000) 1.11
Antigens of mammalian cell cultures. I. Species-specific antigens. Lab Invest (1967) 1.10
Linking iodine with autoimmune thyroiditis. Environ Health Perspect (1999) 1.10
Thyroid antibodies in spontaneous autoimmune thyroiditis in the Buffalo rat. J Immunol (1976) 1.10
Autoimmune murine thyroiditis. VIII. Role of different thyroid antigens in the induction of experimental autoimmune thyroiditis. Immunology (1976) 1.08
Fluorescent antibody technic used for identification and typing of Streptococcus pneumoniae. Am J Clin Pathol (1982) 1.08
Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice. Cell Immunol (1992) 1.08
A review of the ethnic differences in breast cancer. Pharmacogenomics (2006) 1.07
SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1. Br J Cancer (2013) 1.06
Induction of multiple heart autoantibodies in mice with coxsackievirus B3- and cardiac myosin-induced autoimmune myocarditis. J Immunol (1994) 1.06
Iodination of human thyroglobulin (Tg) alters its immunoreactivity. I. Iodination alters multiple epitopes of human Tg. Clin Exp Immunol (1998) 1.06
The frequency and reasons for antiretroviral switching with specific antiretroviral associations: the SWITCH study. Antiviral Res (2010) 1.05
Experimental thyroiditis in the rhesus monkey. II. Precipitating, haemagglutinating and anaphylactogenic antibodies. Clin Exp Immunol (1966) 1.05
Autoantigenic determinants on human thyroglobulin. II. Determinants recognized by autoantibodies from patients with chronic autoimmune thyroiditis compared to autoantibodies from healthy subjects. Clin Immunol Immunopathol (1990) 1.05
Experimental thyroiditis in the rhesus monkey. IV. The role of thyroglobulin and cellular antigens. Clin Exp Immunol (1968) 1.04
The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours. Br J Cancer (2006) 1.04
Autoimmunity and lymphoma: tribulations of B cells. Nat Immunol (2001) 1.03
Splitting of human thyroglobulin. II. Enzymatic digestion. Clin Exp Immunol (1969) 1.01
Racial and age-related differences in incidence and severity of focal autoimmune thyroiditis. Am J Clin Pathol (1994) 1.01
LPS promotes CB3-induced myocarditis in resistant B10.A mice. Cell Immunol (1991) 1.01
Thyroid autoantibodies in black and in white children and adolescents with type 1 diabetes mellitus and their first degree relatives. Autoimmunity (1990) 1.00
Iodine is essential for human T cell recognition of human thyroglobulin. Autoimmunity (1998) 1.00